Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.
about
Hepatocellular carcinoma and the risk of occupational exposureCCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaKlotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinomaAre hematopoietic stem cells involved in hepatocarcinogenesis?Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateAn orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers.The effect of environmental chemicals on the tumor microenvironmentPDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerCausal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular CarcinomaIntegrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.Macro- and micro-environmental factors in clinical hepatocellular cancer.Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse ModelsExtracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesisDynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesisHuman umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapyExperimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum.Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinomaTranscriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out.The Gordian Knot of dysbiosis, obesity and NAFLD.Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor CapsuleAlcohol and inflammatory responses: summary of the 2013 Alcohol and Immunology Research Interest Group (AIRIG) meeting.Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YAUpregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancerEvaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in miceDifferential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.
P2860
Q26750646-CB390972-2893-42E3-81F9-8B73C58B0025Q26779818-6B48EE24-0167-49A0-B3B7-D28E01F014EBQ26784412-003E423C-E0CC-4ADE-B563-8F3FE9B6234FQ26799745-38AAF4D4-3344-406D-AE74-81845E514A81Q26830307-7A961E5E-9C57-45FB-AC25-3A4BD4A94D5CQ26851211-346D3578-8E07-4C99-BDAB-378244D1FA2EQ27003050-95BE984C-0F8D-4290-B665-6E95A6D1C421Q27310334-34DEC066-AA01-4DAB-9F41-7E746A5513D0Q27310369-7985E3EE-1EBE-46AB-93CC-93E92F68D2E7Q28085138-0C2D47A5-6272-4C75-AEE4-2D5933AD7E81Q28085644-427B4055-3CF6-4B0F-A67E-0D07038F6E7BQ28547556-ACDF4353-1BF1-4BF1-A75B-E90F6C27C82CQ30397531-75BC1389-F273-4DD5-A1EE-8A3A5D9534DFQ33600604-655DF00F-6BE8-49C0-9049-C85E710EC50EQ33722638-7F72F20B-1BEB-4A4D-92D3-F37849D89B39Q33729015-CF24D87E-81E7-4A58-AEC1-E52D3B1DC1D5Q33733021-1756CE27-8B11-4D5A-BA05-7FB4586354CFQ33806379-508A85F5-051C-4919-8B46-1B45EB530A43Q33829431-BF60DD85-79E4-4511-971B-BC2F38A4D239Q33851416-95EA459C-0093-4493-B813-2BB216A7459EQ34043094-97BEB7BC-A6E6-48B4-BF60-78279057F619Q34069568-6FA87B65-2B71-4772-BF0A-BEAD79F7B4DCQ34079748-C3B04588-2C5B-4550-A08D-A58997ED0C86Q34364727-99E6603E-063E-4CE7-BD4B-68DAAA6D4A5CQ34452728-E1719830-03D1-4581-9AE5-7FC8A671FE68Q34485560-4B172590-3903-4E65-A202-ADC9687A28ADQ34496914-645740C3-74CC-4836-BD8C-0A5E9833FEBEQ34728237-CCE43634-3532-447F-B258-7243903CCBC9Q34956813-8EEFF563-CECE-4F50-9010-73A6B731B8C6Q34990566-84A0D00A-21A4-4B10-9E7C-BBFBC483DF55Q35028814-507DB3EA-F9B9-46A7-8CC2-76696AB6E27AQ35040147-D5112961-64AB-4F74-A732-375CEC833E6EQ35169362-A3320121-4CBA-4408-A040-E5C21CC6848BQ35176008-5F75F88C-570B-4793-9AD1-568B3E539D0CQ35197467-C18FDFC6-74CB-480E-9C54-45BCE06B1E34Q35237312-8D1D3FC2-9A14-4EC5-B373-5849E911F84DQ35298123-E123AE5C-FF6B-4870-9213-695370562511Q35528287-034014CB-E492-4C6F-A162-8A3E86459AB1Q35571279-B9D1C829-AB10-489C-88E5-AC39503CE53FQ35619104-D2D7E98A-3413-4FDC-B83E-65487671540F
P2860
Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@ast
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@en
type
label
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@ast
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@en
prefLabel
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@ast
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@en
P2860
P1433
P1476
Role of the microenvironment i ...... t of hepatocellular carcinoma.
@en
P2093
Sara Toffanin
Scott L Friedman
P2860
P304
P356
10.1053/J.GASTRO.2013.01.002
P407
P577
2013-01-09T00:00:00Z